| Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation M Delvecchio, J Gaucher, C Aguilar-Gurrieri, E Ortega, D Panne Nature structural & molecular biology 20 (9), 1040-1046, 2013 | 252 | 2013 |
| A systematic screen for protein–lipid interactions in Saccharomyces cerevisiae O Gallego, MJ Betts, J Gvozdenovic‐Jeremic, K Maeda, C Matetzki, ... Molecular systems biology 6 (1), 430, 2010 | 178 | 2010 |
| SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity B Trinité, F Tarrés-Freixas, J Rodon, E Pradenas, V Urrea, S Marfil, ... Scientific Reports 11 (1), 2608, 2021 | 97 | 2021 |
| Structural evidence for Nap1‐dependent H2A–H2B deposition and nucleosome assembly C Aguilar‐Gurrieri, A Larabi, V Vinayachandran, NA Patel, K Yen, R Reja, ... The EMBO journal 35 (13), 1465-1482, 2016 | 87 | 2016 |
| Production of HIV-1-based virus-like particles for vaccination: Achievements and limits L Cervera, F Gòdia, F Tarrés-Freixas, C Aguilar-Gurrieri, J Carrillo, ... Applied microbiology and biotechnology 103, 7367-7384, 2019 | 50 | 2019 |
| CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis X Crespo-Yàñez, C Aguilar-Gurrieri, AC Jacomin, A Journet, M Mortier, ... PLoS genetics 14 (6), e1007456, 2018 | 43 | 2018 |
| New emerging targets in cancer immunotherapy: the role of neoantigens L De Mattos-Arruda, J Blanco-Heredia, C Aguilar-Gurrieri, J Carrillo, ... ESMO open 4, e000684, 2019 | 33 | 2019 |
| An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses F Tarrés-Freixas, C Aguilar-Gurrieri, ML Rodríguez de la Concepción, ... npj Vaccines 8 (1), 51, 2023 | 12 | 2023 |
| HIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission D Perez-Zsolt, D Raïch-Regué, J Muñoz-Basagoiti, C Aguilar-Gurrieri, ... Pathogens 11 (1), 39, 2021 | 5 | 2021 |
| Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity R Ortiz, A Barajas, A Pons-Grífols, B Trinité, F Tarrés-Freixas, C Rovirosa, ... International Journal of Molecular Sciences 24 (10), 9025, 2023 | 4 | 2023 |
| Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines C Aguilar-Gurrieri, A Barajas, C Rovirosa, R Ortiz, V Urrea, N de la Iglesia, ... Cancer Immunology, Immunotherapy 72 (7), 2113-2125, 2023 | 3 | 2023 |
| Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization E Pradenas, S Marfil, V Urrea, T Pidkova, A Pons-Grífols, R Ortiz, ... Iscience 26 (4), 2023 | 3 | 2023 |
| Full wwPDB X-ray Structure Validation Report i H Wang, E Gouaux Word wide protein data bank, 2009 | 2 | 2009 |
| Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant C Ávila-Nieto, J Vergara-Alert, P Amengual-Rigo, E Ainsua-Enrich, ... Frontiers in immunology 14, 1291972, 2023 | 1 | 2023 |
| VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice B Trinité, E Durr, A Pons-Grífols, G O'Donnell, C Aguilar-Gurrieri, ... Vaccine, 2024 | | 2024 |
| Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection C Ávila-Nieto, J Vergara-Alert, P Amengual-Rigo, E Ainsua-Enrich, ... Nature Communications 15 (1), 2349, 2024 | | 2024 |
| Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice A Barajas, P Amengual-Rigo, A Pons-Grífols, R Ortiz, O Gracia Carmona, ... Journal of Translational Medicine 22 (1), 14, 2024 | | 2024 |
| Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 and golden Syrian hamster upon SARS-CoV-2 infection. J Carrillo, C Ávila-Nieto, J Vergara-Alert, P Amengual-Rigo, ... | | 2023 |
| P03. 01 High immunogenic VLP-based vaccines elicit new T cell specificities against melanoma neoantigens in mice C Aguilar-Gurrieri, A Barajas, A Pons-Grifols, I Varela, P Amengual-Rigo, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 1), 2021 | | 2021 |
| An enveloped virus-like particle (VLP) platform with high-density antigen display induces a strong and functional humoral immune response F Tarres-Freixas, C Aguilar-Gurrieri, LM Molinos-Albert, I Varela, R Ortiz, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 24, 2021 | | 2021 |
Julià BlancoIGTP, IRSICAIXA, UAB, UVIC-UCCVerified email at irsicaixa.es
